Cidara Therapeutics Inc
F:20D0
Cidara Therapeutics Inc
F:20D0
Price:
183
EUR
Market Cap:
€5.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
T
|
Toray Industries Inc
OTC:TRYIF
|
JP |
|
Stepan Co
NYSE:SCL
|
US |
|
Celanese Corp
NYSE:CE
|
US |
|
Open Lending Corp
NASDAQ:LPRO
|
US |
|
M
|
Mondi PLC
SWB:KYC
|
UK |
|
GAIL (India) Ltd
F:GQI
|
IN |
|
A
|
Agilysys Inc
F:PS3
|
US |
|
Lagardere SA
F:LAG
|
FR |
|
Information Services Group Inc
NASDAQ:III
|
US |
|
Coronado Global Resources Inc
OTC:CODQL
|
AU |
|
S
|
Summit Materials Inc
F:7SU
|
US |
|
U
|
Unilever PLC
F:UNVB
|
UK |
|
Sartorius AG
OTC:SUVPF
|
DE |
|
Logitech International SA
F:LTEC
|
CH |
|
I
|
Interpublic Group of Companies Inc
DUS:IPG
|
US |
|
I
|
Interpublic Group of Companies Inc
XMUN:IPG
|
US |
|
Yoshiharu Global Co
NASDAQ:VSTD
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 20D0's stock price target?
Not Available
20D0 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cidara Therapeutics Inc?
Projected CAGR
318%
318%
The compound annual growth rate for Revenue over the next 4 years is 318%.
